Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash from Operations (2018 - 2026)

DiaMedica Therapeutics filings provide 9 years of Cash from Operations readings, the most recent being 9100000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 27.29% to 9100000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 31013000.0 through Mar 2026, down 37.4% year-over-year, with the annual reading at 29062000.0 for FY2025, 31.65% down from the prior year.
  • Cash from Operations hit 9100000.0 in Q1 2026 for DiaMedica Therapeutics, down from 7762000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2361000.0 in Q3 2022 and bottomed at 9100000.0 in Q1 2026.
  • Average Cash from Operations over 5 years is 5322176.47, with a median of 5030000.0 recorded in 2023.
  • The largest annual shift saw Cash from Operations grew 22.49% in 2022 before it crashed 103.18% in 2023.
  • DiaMedica Therapeutics' Cash from Operations stood at 2766000.0 in 2022, then plummeted by 37.82% to 3812000.0 in 2023, then tumbled by 68.78% to 6434000.0 in 2024, then dropped by 20.64% to 7762000.0 in 2025, then dropped by 17.24% to 9100000.0 in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Cash from Operations are 9100000.0 (Q1 2026), 7762000.0 (Q4 2025), and 6600000.0 (Q3 2025).